Menu
Back to Journals » OncoTargets and Therapy » Volume 11
Review
Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 15,317 | Dovepress* | 9,702+ | 1,013 | 10,715 | |
| PubMed Central* | 5,615 | 737 | 6,352 | ||
| Totals | 15,317 | 1,750 | 17,067 | ||
| *Since 14 December 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 3 | 5 |
View citations on PubMed Central and Google Scholar